{"disease":{"id":"cancer-of-the-endometrium","name":"cancer of the endometrium"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03169023","title":"Scale Down for Endometrial Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04080284","title":"Trial of Maintenance With Niraparib- Uterine Serous Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT03955978","title":"TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Washington University School of Medicine","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}